Article | July 9, 2021

Enabling Broader Adoption Of Process Intensification In Biopharma

Source: Sartorius

By Ganesh Kumar, Sartorius

PI Clean

PI is becoming increasingly well-understood and its utility is continuously evolving to meet specific manufacturer needs, from product development to manufacturing, whether approached stepwise or end-to-end.

The benefits of process intensification (PI) in biopharmaceutical manufacturing are well established: PI enables manufacturers to increase volumetric productivity, reduce timelines, decrease facility footprint, lower costs, or improve flexibility. However, knowledge about PI implementation — from the costs to the technological and regulatory aspects, and risk mitigation — is less ubiquitous.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: